Novarad’s OpenSight Augmented Reality System is the first AR medical solution for Microsoft HoloLens cleared by the FDA receiving 510(k) clearance for use in pre-operative surgical planning. The technology renders 2D, 3D and 4D images of patients interactively, while accurately overlaying them directly onto the patient’s body. The solution, along with patented virtual tool technology and an integrated targeting system, allows doctors to see the patient and into the patient simultaneously to more accurately plan surgery. The internal visualization can now be achieved without the surgeon ever making an incision.
“This is transformative technology that will unite preoperative imaging with augmented reality to improve the precision, speed and safety of medical procedures,” stated Dr. Wendell Gibby, Novarad CEO and co-creator of OpenSight.
First Augmented Reality Solution For Hololens Cleared By The Fda
Thursday, November 1, 2018
News